Melodia Therapeutics AG
PrivateLast Round
Series A
Sep 2, 2025
Company Overview
Melodia Therapeutics AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Seed round in June 2024.
Melodia Therapeutics AG is a biotechnology company focused on developing oral therapies that target neutrophil-driven inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melodia Therapeutics AG Comparables
Compare Melodia Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insmed Incorporated | 75% | |
| Chiesi Farmaceutici S.p.A. | 74% | |
| Haisco Pharmaceutical Group | 74% |
For institutional investors. Book with your work email.
Melodia Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 2, 2025 | ||||
| Seed | Jun 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Melodia Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forty51 Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 130% MoM, reaching 3.5K.
- Mar 6, 2026
Monthly visitors grew 2199% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
Melodia Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Melodia Therapeutics AG's valuation, stock price, and market status.
Is Melodia Therapeutics AG a public or private company?
Melodia Therapeutics AG is a private company.
What is the current stock price of Melodia Therapeutics AG?
Melodia Therapeutics AG is a private company, so its shares have no public market price. Caplight tracks Melodia Therapeutics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Melodia Therapeutics AG worth (valuation)?
Valuation information for Melodia Therapeutics AG is not publicly available.
Can I buy Melodia Therapeutics AG stock?
Melodia Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Melodia Therapeutics AG's last funding round?
Melodia Therapeutics AG's most recent funding round was Series A on September 2, 2025.
Who are the main investors in Melodia Therapeutics AG?
Key investors in Melodia Therapeutics AG include Forty51 Ventures.
Will Melodia Therapeutics AG IPO soon?
No public IPO plans have been announced for Melodia Therapeutics AG.
How can I track Melodia Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades in Melodia Therapeutics AG's shares on secondary markets.